Which stock in the fund do you think is most undervalued by the market and why? CSL’s share price has fallen 20 per cent over the last six months despite selling largely non-discretionary ...

Learn More The CSL Ltd (ASX: CSL) share price has fallen twice as fast as the benchmark index in 2025. CSL shares have fallen 10.86% in the year to date, while the S&P/ASX 200 Index (ASX ...

I maintain a Neutral view on CSL Limited due to the mixed prospects for its flu vaccine ("Seqirus") and plasma therapy ("Behring") segments. Seqirus is witnessing revenue declines as a result of ...

It is hard to get excited after looking at Carlisle Companies' (NYSE:CSL) recent performance, when its stock has... Wrapping up Q4 earnings, we look at the numbers and key takeaways for the ...

Trunks run high, hatches low. The manufacturer standard greatly underestimates trunk volume, so Cars.com’s numbers are consistently higher. Conversely, our numbers for anything with a liftgate ...

1996-2004 BMW E46 4th-gen 3-series, 1999-2005 BMW E60 5th-gen 5-series, 2004-2010 BMW E61 5th-gen 5-series Touring, 2004-2010 BMW E63 2nd-gen 6-series Coupe, 2003-2011 BMW E64 2nd-gen 6-series ...

CSL Ltd isn’t merely an Australian success story: it’s also a global leader of its field. In recent years it’s ranked among the largest (by market capitalisation) companies listed on the ASX (on 7 ...

Research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines.